Guardant Health (GH) EV to EBITDA (2018 - 2026)

Guardant Health has disclosed EV to EBITDA across 9 years of filings, most recently posting 147.09 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 167.63% year-over-year to 147.09; the TTM figure through Jun 2026 stood at 40.39 (down 218.16% YoY), while the FY2025 annual figure was 27.77, down 317.83% from the prior year.
• EV to EBITDA came in at 147.09 for Q2 2026 at Guardant Health, down from 91.02 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 10.74 in Q4 2023 to a low of 147.09 in Q2 2026.
• Average EV to EBITDA over 5 years is 42.86, with a median of 25.55 recorded in 2022.
• Year-over-year, EV to EBITDA soared 87.06% in 2022 and plunged 344.14% in 2025.
• Over 5 years, EV to EBITDA stood at 12.18 in 2022, then rose by 11.83% to 10.74 in 2023, then sank by 117.89% to 23.4 in 2024, then tumbled by 329.44% to 100.5 in 2025, then sank by 46.35% to 147.09 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 147.09 in Q2 2026, 91.02 in Q1 2026, and 100.5 in Q4 2025.